id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-2484-0001,FDA,FDA-2019-N-2484,Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Continuous Glucose Monitor Data Management System,Rule,Final Rule,2019-10-29T04:00:00Z,2019,10,2019-10-29T04:00:00Z,,2019-10-30T14:25:27Z,2019-23471,0,0,0900006484103fca